To determine if MAG-induced RIP processing of p75 is required for the inhibitory effects of MAG, we blocked kDa band along with other smaller bands that represent heterogeneously glycosylated forms of the protein γ-secretase activity by adding a specific inhibitor, compound X, to the neurite outgrowth assay. As we have (Grob et al., 1985) . To clarify the relationship between proteolytic processing of p75 and MAG-induced signalreported before (Mukhopadhyay et al., 1994) , when cerebellar neurons are cultured on a monolayer of MAGing, we first added inhibitors of different proteolytic enzymes or a PKC inhibitor, followed by either of two expressing CHO cells, they extend processes that are about 70% shorter than when grown on control CHO chimeric forms of MAG. MAG-Fc comprises the entire five Ig-like extracellular domains fused to the Fc portion cells not expressing MAG (Figures 2A and 2B) . In sharp contrast, however, when the γ-secretase inhibitor is inof human IgG and has been shown to inhibit axonal growth (Tang et al., 1997). MAG (1-3)-Fc, which lacks cluded in the cocultures, MAG has no effect on neurite outgrowth; processes are the same length on MAGthe fourth and fifth Ig-like domains, binds to neurons in a specific, sialic acid-dependent manner, but it is not expressing cells as on control cells. Similar results were found when an α-secretase inhibitor, TAPI-1, was ininhibitory (Tang et al., 1997). For p75 and other proteins that undergo RIP processing, it has been reported that cluded in the cocultures. The PKC inhibitor Go6976 also completely blocked inhibition of neurite outgrowth the second cleavage leaves a cytoplasmic fragment that is degraded too rapidly for detection unless a proby MAG ( Fas does not undergo RIP. Figure 3A is a diagram reprenot inhibited from extending processes; growth was the same as on the control cells not expressing MAG. As a senting the chimeric proteins. The protein in which the TM domain is replaced is termed p75-FasTM, and the control, overexpression of wild-type p75 had no effect on inhibition by MAG ( Figures 3C and 3D ). Furthermore, protein where the stalk domain is replaced is termed p75-FasS. Following transfection into NG108, both of when a cDNA coding for only the ICD of p75 is transfected into NG108 cells, neurite outgrowth on the conthese chimeric proteins are expressed at significantly higher levels (5-to 6-fold) than endogenous p75 (see trol cells, not expressing MAG, is inhibited to the same extent as on MAG-expressing cells. This indicates that Figure S1A in the Supplemental Data online). In addition, from surface biotinylation and precipitation studies the ICD of p75 is, alone, sufficient to inhibit neurite outgrowth in the absence of MAG. Next, the chimeric rewe show that each reaches the cell surface and is able to interact with the NgR receptor (Figures S1B and ceptors were each expressed in primary, dorsal root ganglion (DRG) neurons. As with the NG108 cells, the DRG S1D). When the wild-type p75 is expressed in 293 cells, both the w30 kDa CTF and the w25 kDa ICD are clearly neurons expressing either of the chimeric receptors are not inhibited by MAG; growth on MAG-expressing cells is visible after PMA treatment ( Figure 3B ). For the p75-FasTM chimera, only the w30 kDa fragment appeared the same as on the control cells not expressing MAG (Figure 3E) . Also like the NG108 cells, overexpression of wildafter PMA treatment, while the p75-FasS chimera, under similar conditions, did not display any cleaved type p75 has no effect on inhibition by MAG ( Figure 3E ). Therefore, expression of the cleavage-resistant p75 products. This lack of cleavage of the p75-FasTM chimera is consistent with the localization of the γ-secreconstructs in neurons blocked inhibition by MAG, confirming the results obtained by pharmacological inhibitase site in the transmembrane domain (Zampieri et al., 2005). In contrast, for the p75-FasS chimera, only the tors, namely that MAG-induced cleavage of p75 is crucial to effect inhibition. α-secretase site is lost from p75, and although the p75 γ-secretase site is present in the chimera, cleavage at the γ site must be preceded by cleavage at the α-secre (Figure 4, lanes 1 and 2) . The MAG-Fcage-resistant forms of p75 also block inhibition by induced activation of Rho is returned to baseline levels in the presence of a γ-secretase inhibitor, an α-secretase inhibitor, or either of two inhibitors of PKC ( Figure  4, lanes 6-9) . The results indicate that MAG activation of Rho requires RIP processing of the p75 neurotrophin receptor.
Discussion
Based on the results reported here, we propose a mechanism of how myelin inhibitors act: MAG induces cleavage of p75, a component of the NgR complex, by 
